Diagnostic News and Research

RSS

Cardiac Science and OMRON Healthcare sign distribution agreement

Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, entered into an exclusive agreement with OMRON Healthcare distribute Omron's vital signs and spot check monitors under the Cardiac Science brand in the United States and Canada.

20 Oct 2009

ImmunoCellular Therapeutics files a provisional patent application

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today that it has filed a provisional patent application at US Patent Office seeking protection of intellectual property relating to novel glycosylated epitopes present in lung cancer, pancreatic cancer and colon cancer that are targeted by the Company’s ICT-109 monoclonal antibody product candidate.

20 Oct 2009

Study explores the efficacy of antidepressant drugs for patients with severe depression and medical disorder

This study demonstrates that over 6 weeks of treatment, patients with melancholic depression and medical comorbidity (MC) (specifically cardiovascular or endocrinological MC) had poorer treatment response and a worse functional outcome as opposed to their counterparts without MC. Interestingly, these effects were not related to various antidepressant treatment regimens.

20 Oct 2009

Biomagnetics Diagnostics to raise $1 million

Biomagnetics Diagnostics Corp. (Pink Sheets:BMGP), a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced the completion of its equity financing designed to fund entry into the Integrated Optical Biosensor Systems (IOBS) market.

20 Oct 2009

Health Discovery Corporation granted additional patents for Recursive Feature Elimination using Support Vector Machines

Health Discovery Corporation is pleased to announce numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio. The Company now has a total of 37 issued patents, 4 Notices of Allowance and 30 pending patent applications.

20 Oct 2009

Current medical assessment not sufficient; clinimetric methods may improve final outcomes

In a paper published in the current issue of Psychotherapy and Psychosomatics, Giovanni A. Fava (University of Bologna) and Nicoletta Sonino (University of Padova) summarize data which indicate that current medical assessment, by ignoring the psychosocial dimensions, is inadequate in most of medical encounters

19 Oct 2009

Durham VA Medical Center receives Daxor's BVA-100 Blood Volume Analyzer

Daxor Corporation, a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the Institute for Medical Research at the Durham Veterans Affairs (VA) Medical Center of Durham, North Carolina.

19 Oct 2009

Bederra Corporation to acquire Texas Mobile Health

Bederra Corporation, a Houston, Texas based diversified medical services provider, announced that the company has signed a Letter of Intent to acquire Texas Mobile Health, Inc.

19 Oct 2009

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough announced that data on boceprevir, an investigational hepatitis C virus (HCV) protease inhibitor, will be reported in an oral presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston, Oct. 30-Nov. 3.

19 Oct 2009

Children's Hospital Boston's CRAFFT substance abuse diagnostic test helps identify high risk sexual behavior

Alcohol and drug use are known contributors to adolescents engaging in dangerous sexual activity; leading to substantial health risks such as unwanted pregnancies, sexually transmitted illnesses, drug overdoses and alcohol poisonings. Yet, research suggests that fewer than half of pediatricians report screening patients for substance use and at-risk sexual behavior.

19 Oct 2009

FDA approves Quotient Biodiagnostics' BLA for transfusion diagnostic monoclonal antibodies

Quotient Biodiagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products are for use by blood donor centers, reference laboratories, and hospitals to type and screen blood.

19 Oct 2009

Phase 3 clinical trial of macimorelin (AEZS-130) to be completed by AEterna Zentaris

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD). Macimorelin is the International Non-proprietary Name (INN) designated for the compound by the World Health Organization (WHO).

19 Oct 2009

Chinese SFDA approves China Medical Technologies' SPR System

China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its SPR- based analysis system (the "SPR System") from the State Food and Drug Administration of China (the "SFDA").

19 Oct 2009

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.

19 Oct 2009

New chromosomal abnormality in acute lymphoblastic leukemia

Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome.

19 Oct 2009

CCID Consulting releases article on China’s portable medical electronics field

CCID Consulting, China’s leading research, consulting and IT outsourcing service provider, and the first Chinese consulting firm listed in Hong Kong (Hong Kong Stock Exchange: HK08235), released its article on China’s portable medical electronics field.

19 Oct 2009

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Persistent inflammation and the activation of the immune system is the key pathological mechanism affecting many long-term conditions, such as rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease and is the predominant mechanism underlying organ transplant rejection.

19 Oct 2009

Chembio Diagnostics to supply over 2000 PrimaTB STAT-PAK tuberculosis testing kits

Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, has agreed to provide over 2,000 PrimaTB STAT-PAK tuberculosis (TB) testing kits which are approved for use in Macaques to the Orangutan Conservancy (OC) to support the organization's continued drive to raise the level of veterinary care at orangutan rehabilitation centers.

19 Oct 2009

Cancer Therapeutics and Nanotherapies sign letter of intent

Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.

19 Oct 2009

New EVestG diagnostic technique aids in quick detection of mental and neurological illnesses

An innovative diagnostic technique invented by a Monash University researcher could dramatically fast-track the detection of mental and neurological illnesses.

19 Oct 2009

Diagnostic News and Research

Cardiac Science and OMRON Healthcare sign distribution agreement

ImmunoCellular Therapeutics files a provisional patent application

Study explores the efficacy of antidepressant drugs for patients with severe depression and medical disorder

Biomagnetics Diagnostics to raise $1 million

Health Discovery Corporation granted additional patents for Recursive Feature Elimination using Support Vector Machines

Current medical assessment not sufficient; clinimetric methods may improve final outcomes

Durham VA Medical Center receives Daxor's BVA-100 Blood Volume Analyzer

Bederra Corporation to acquire Texas Mobile Health

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Children's Hospital Boston's CRAFFT substance abuse diagnostic test helps identify high risk sexual behavior

FDA approves Quotient Biodiagnostics' BLA for transfusion diagnostic monoclonal antibodies

Phase 3 clinical trial of macimorelin (AEZS-130) to be completed by AEterna Zentaris

Chinese SFDA approves China Medical Technologies' SPR System

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

New chromosomal abnormality in acute lymphoblastic leukemia

CCID Consulting releases article on China’s portable medical electronics field

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Chembio Diagnostics to supply over 2000 PrimaTB STAT-PAK tuberculosis testing kits

Cancer Therapeutics and Nanotherapies sign letter of intent

New EVestG diagnostic technique aids in quick detection of mental and neurological illnesses

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News